SOCS2 and hepatocellular carcinoma: A previous study found that the overexpression of METTL3 in hepatocellular carcinoma (HCC) may promote the degradation of the SOCS2 gene, resulting in an abnormal JAK/STAT signaling pathway, causing the proliferation and migration of HCC cells [37].